From the Journals

2025 ESMO Bladder Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from ESMO 2025.

  • November 17, 2025

Share

Related Content

This Week’s Biopharma News: New Restrictions on Sarepta Gene Therapy

Our latest news roundup reports on the FDA’s new “plausible mechanism” pathway, Novartis’s phase III malaria trial, a new gene therapy in Europe, and more.

  • November 18, 2025

  • 5 min
2025 ESMO Kidney Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates you need to know from ESMO 2025.

  • November 17, 2025

2025 ESMO Prostate Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from ESMO 2025

  • November 17, 2025